The naming of diseases is a complex process that involves several factors, including scientific considerations, avoiding stigmatization of specific regions or populations, and ensuring effective communication to the public. The World Health Organization (WHO) has guidelines for naming diseases to minimize any negative impact on specific countries or communities.

In 2015, the WHO released guidelines for the naming of infectious diseases, which discourage the use of names based on geographic locations, animal species, or individual names. This is because such names can perpetuate stigma, lead to discrimination, and have negative consequences for affected populations.

While it is true that diseases have historically been named after their place of origin, such as the Spanish flu or Middle East Respiratory Syndrome (MERS), the WHO has made efforts to move away from this practice to prevent unnecessary association between diseases and specific geographic locations or communities.

The naming of diseases is a sensitive issue, and the WHO aims to strike a balance between providing accurate information and avoiding the potential for stigmatization or discrimination. It is important to approach discussions about disease naming with an understanding of these complexities and the intention behind the WHO's guidelines.